Core Insights - Pianzaihuang has been recognized as a "Chinese brand worth recommending to the world" at the 2025 China-France Brand Week in Paris, highlighting its efforts in promoting traditional Chinese medicine internationally [1] Group 1: Company Overview - Pianzaihuang Pharmaceutical Co., Ltd., established in 1999, focuses on pharmaceutical manufacturing, with products including liver disease medications, cold remedies, and dermatological treatments, while also expanding into daily chemicals and health foods [1] - The company has seen a year-on-year increase in sales of Pianzaihuang capsules, primarily among consumers under 40 years old [1] - Pianzaihuang is actively involved in the "Round Mountain Plan" in Zhangzhou, signing contracts with 240 renowned doctors and establishing four medical studios, serving 225,000 people [1] Group 2: Research and Development - A recent study by Professor Yu Jun's team at the Chinese University of Hong Kong has drawn attention to Pianzaihuang's role in preventing and treating non-alcoholic fatty liver disease [2] - The company has established an innovation research base in Daxing District, Beijing, planning to create a cultural and product display center that integrates product experience, cultural promotion, and traditional Chinese medicine consultations [2] Group 3: International Expansion - Pianzaihuang is actively exploring overseas markets, conducting market assessments in Brazil, Argentina, Singapore, and Malaysia to find quality partners for deep cooperation [3] - The company has obtained registration approvals for multiple traditional Chinese medicine products in countries like Laos and Mozambique, enhancing its international market access [2]
努力推动中医药国际化